Canlyniadau Chwilio - Gaffey, Sarah

ACTR-93. A PHASE I STUDY OF MLN0128 (TAK-228) AND BEVACIZUMAB IN PATIENTS WITH ADVANCED SOLID TUMORS INCLUDING GLIOBLASTOMA gan Nayak, Lakshmi, Hays, John, Do, Khanh, Muzikansky, Alona, Gaffey, Sarah, Lee, Eudocia, Rinne, Mikael, Norden, Andrew, Beroukhim, Rameen, Puduvalli, Vinay, Wen, Patrick, Doyle, L Austin, Chen, Helen, Shapiro, Geoffrey, Reardon, David

Cael y testun llawn Cael y testun llawn

AT-36 PANOBINOSTAT IN COMBINATION WITH BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA AND ANAPLASTIC GLIOMA gan Lee, Eudocia, Reardon, David, Schiff, David, Drappatz, Jan, Muzikansky, Alona, Grimm, Sean, Norden, Andrew, Nayak, Lakshmi, Beroukhim, Rameen, Rinne, Mikael, Chi, Andrew, Batchelor, Tracy, Hempfling, Kelly, McCluskey, Christine, Smith, Katrina, Gaffey, Sarah, Wrigley, Brendan, Ligon, Keith, Raizer, Jeffrey, Wen, Patrick

Cael y testun llawn Cael y testun llawn

AT-37 PHASE I STUDY OF PLERIXAFOR AND BEVACIZUMAB IN RECURRENT HIGH-GRADE GLIOMA gan Lee, Eudocia, Smith, Katrina, Muzikansky, Alona, Gerstner, Elizabeth, Kuhn, John, Reardon, David, Nayak, Lakshmi, Norden, Andrew, Rifenburg, Jennifer, Pulverenti, Julee, Stokes, Deirdre, Lam, Priscilla, Martins, Tiago, Hempfling, Kelly, McCluskey, Christine, Gaffey, Sarah, Batchelor, Tracy, Duda, Dan, Jain, Rakesh, Wen, Patrick

Cael y testun llawn Cael y testun llawn

SM-03 A RANDOMIZED, PLACEBO-CONTROLLED PILOT TRIAL OF ARMODAFINIL FOR FATIGUE IN PATIENTS WITH GLIOMAS UNDERGOING RADIOTHERAPY gan Lee, Eudocia, Muzikansky, Alona, Kesari, Santosh, Wong, Eric, Fadul, Camilo, Reardon, David, Norden, Andrew, Nayak, Lakshmi, Rinne, Mikael, Alexander, Brian, Arvold, Nils, Doherty, Lisa, LaFrankie, Debra, Pulverenti, Julee, Smith, Katrina, Gaffey, Sarah, Kenney, Alexandra, Hammond, Samantha, Drappatz, Jan, Wen, Patrick

Cael y testun llawn Cael y testun llawn

ATIM-12. NEOADJUVANT ANTI-PD-1 IMMUNOTHERAPY PROMOTES INTRATUMORAL AND SYSTEMIC IMMUNE RESPONSES IN RECURRENT GLIOBLASTOMA: AN IVY CONSORTIUM TRIAL gan Prins, Robert, Mochizuki, Aaron, Orpilla, Joey, Lee, Alexander, Davidson, Tom, Gaffey, Sarah, Sanders, Catherine, Rytlewski, Julie, Ellingson, Benjamin, Li, Gang, Yong, William, Clarke, Jennifer, Arrillaga-Romany, Isabel, Colman, Howard, Reardon, David, Kaley, Thomas, de Groot, John, Liau, Linda, Wen, Patrick, Cloughesy, Timothy

Cael y testun llawn Cael y testun llawn

ACTR-76. FINAL RESULTS FROM A PHASE I STUDY OF PLERIXAFOR AND BEVACIZUMAB IN RECURRENT HIGH-GRADE GLIOMA gan Lee, Eudocia, Muzikansky, Alona, Gerstner, Elizabeth, Kuhn, John, Reardon, David, Nayak, Lakshmi, Norden, Andrew, Doherty, Lisa, Stefanik, Jennifer, Armitage, Julee, LaFrankie, Debra, Ruland, Sandra, Vardam, Trupti, Stokes, Deirdre, Smith, Katrina, McCluskey, Christine, Gaffey, Sarah, Batchelor, Tracy, Jain, Rakesh, Duda, Dan, Wen, Patrick

Cael y testun llawn Cael y testun llawn

Phase II trial of ponatinib in patients with bevacizumab‐refractory glioblastoma gan Lee, Eudocia Q., Muzikansky, Alona, Duda, Dan G., Gaffey, Sarah, Dietrich, Jorg, Nayak, Lakshmi, Chukwueke, Ugonma N., Beroukhim, Rameen, Doherty, Lisa, Laub, Caroline Kane, LaFrankie, Debra, Fontana, Brittney, Stefanik, Jennifer, Ruland, Sandra, Caruso, Victoria, Bruno, Jennifer, Ligon, Keith, Reardon, David A., Wen, Patrick Y.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

NCOG-44. NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE IN A PHASE II STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA gan Nayak, Lakshmi, Molinaro, Annette, Peters, Katherine, Clarke, Jennifer, Jordan, Justin, de Groot, John, Nghiemphu, Phioanh, Kaley, Thomas, Colman, Howard, McCluskey, Christine, Gaffey, Sarah, Smith, Timothy, Cote, David, Severgnini, Mariano, Yearley, Jennifer, Zhao, Qing, Blumenschein, Wendy, Duda, Gabriel, Muzikansky, Alona, Jain, Rakesh, Wen, Patrick, Reardon, David

Cael y testun llawn Cael y testun llawn

Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma gan Lee, Eudocia Q., Reardon, David A., Schiff, David, Drappatz, Jan, Muzikansky, Alona, Grimm, Sean A., Norden, Andrew D., Nayak, Lakshmi, Beroukhim, Rameen, Rinne, Mikael L., Chi, Andrew S., Batchelor, Tracy T., Hempfling, Kelly, McCluskey, Christine, Smith, Katrina H., Gaffey, Sarah C., Wrigley, Brendan, Ligon, Keith L., Raizer, Jeffrey J., Wen, Patrick Y.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma gan Alexander, Brian M., Trippa, Lorenzo, Gaffey, Sarah, Arrillaga-Romany, Isabel C., Lee, Eudocia Q., Rinne, Mikael L., Ahluwalia, Manmeet S., Colman, Howard, Fell, Geoffrey, Galanis, Evanthia, de Groot, John, Drappatz, Jan, Lassman, Andrew B., Meredith, David M., Nabors, L. Burt, Santagata, Sandro, Schiff, David, Welch, Mary R., Ligon, Keith L., Wen, Patrick Y.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy gan Lee, Eudocia Q., Muzikansky, Alona, Drappatz, Jan, Kesari, Santosh, Wong, Eric T., Fadul, Camilo E., Reardon, David A., Norden, Andrew D., Nayak, Lakshmi, Rinne, Mikael L., Alexander, Brian M., Arvold, Nils D., Doherty, Lisa, Stefanik, Jennifer, LaFrankie, Debra, Ruland, Sandra F., Pulverenti, Julee, Smith, Katrina H., Gaffey, Sarah C., Hammond, Samantha, Wen, Patrick Y.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma gan Norden, Andrew D., Ligon, Keith L., Hammond, Samantha N., Muzikansky, Alona, Reardon, David A., Kaley, Thomas J., Batchelor, Tracy T., Plotkin, Scott R., Raizer, Jeffrey J., Wong, Eric T., Drappatz, Jan, Lesser, Glenn J., Haidar, Sam, Beroukhim, Rameen, Lee, Eudocia Q., Doherty, Lisa, Lafrankie, Debra, Gaffey, Sarah C., Gerard, Mary, Smith, Katrina H., McCluskey, Christine, Phuphanich, Surasak, Wen, Patrick Y.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma gan Nayak, Lakshmi, Molinaro, Annette M., Peters, Katherine, Clarke, Jennifer L., Jordan, Justin T., de Groot, John, Nghiemphu, Leia, Kaley, Thomas, Colman, Howard, McCluskey, Christine, Gaffey, Sarah, Smith, Timothy R., Cote, David J., Severgnini, Mariano, Yearley, Jennifer H., Zhao, Qing, Blumenschein, Wendy M., Duda, Dan G., Muzikansky, Alona, Jain, Rakesh K., Wen, Patrick Y., Reardon, David A.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

INNV-13. ALLELE: A CONSORTIUM FOR PROSPECTIVE GENOMICS AND FUNCTIONAL DIAGNOSTICS TO GUIDE PATIENT CARE AND TRIAL ANALYSIS IN NEWLY-DIAGNOSED GLIOBLASTOMA gan Touat, Mehdi, Dubuc, Adrian, Meredith, David, Tsuji, Junko, Mills, Caitlin, Gaffey, Sarah, Geduldig, Jack, Watkinson, Fiona, Pelton, Kristine, Malinowski, Seth, Lennon, Niall, Sorger, Peter, Trippa, Lorenzo, Ramkissoon, Shakti, Reardon, David, de Groot, John, Galanis, Evanthia, Welch, Mary, Nabors, L Burt, Arrillaga-Romany, Isabel, Chiocca, E Antonio, Santagata, Sandro, Schiff, David, Ahluwalia, Manmeet, Colman, Howard, Drappatz, Jan, Alexander, Brian, Wen, Patrick, Ligon, Keith

Cael y testun llawn Cael y testun llawn

INNV-33. BARRIERS TO ACCRUAL AND ENROLLMENT IN BRAIN TUMOR TRIALS gan Lee, Eudocia, Chukwueke, Ugonma, Hervey-Jumper, Shawn, DeGroot, John, Leone, Pablo, Armstrong, Terri, Chang, Susan, Arons, David, Oliver, Kathy, Verble, Kay, Musella, Al, Willmarth, Nicole, Alexander, Brian, Bates, Amanda, Doherty, Lisa, Galanis, Evanthia, Gaffey, Sarah, Halkin, Thomas, Friday, Bret, Fouladi, Maryam, Lin, Nancy, Macdonald, David, Mehta, Minesh, Penas-Prado, Marta, Vogelbaum, Michael, Sahebjam, Solmaz, Sandak, David, van den Bent, Martin, Weller, Michael, Reardon, David, Wen, Patrick

Cael y testun llawn Cael y testun llawn

Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results gan Bi, Wenya Linda, Nayak, Lakshmi, Meredith, David M, Driver, Joseph, Du, Ziming, Hoffman, Samantha, Li, Yvonne, Lee, Eudocia Quant, Beroukhim, Rameen, Rinne, Mikael, McFaline-Figueroa, Ricardo, Chukwueke, Ugonma, McCluskey, Christine, Gaffey, Sarah, Cherniack, Andrew D, Stefanik, Jennifer, Doherty, Lisa, Taubert, Christina, Cifrino, Meghan, LaFrankie, Deborah, Graillon, Thomas, Wen, Patrick Y, Ligon, Keith L, Al-Mefty, Ossama, Huang, Raymond Y, Muzikansky, Alona, Chiocca, E Antonio, Santagata, Sandro, Dunn, Ian F, Reardon, David A

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Barriers to accrual and enrollment in brain tumor trials gan Lee, Eudocia Q, Chukwueke, Ugonma N, Hervey-Jumper, Shawn L, de Groot, John F, Leone, Jose Pablo, Armstrong, Terri S, Chang, Susan M, Arons, David, Oliver, Kathy, Verble, Kay, Musella, Al, Willmarth, Nicole, Alexander, Brian M, Bates, Amanda, Doherty, Lisa, Galanis, Evanthia, Gaffey, Sarah, Halkin, Thomas, Friday, Bret E, Fouladi, Maryam, Lin, Nancy U, Macdonald, David, Mehta, Minesh P, Penas-Prado, Marta, Vogelbaum, Michael A, Sahebjam, Solmaz, Sandak, David, van den Bent, Martin, Weller, Michael, Reardon, David A, Wen, Patrick Y

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma gan Cloughesy, Timothy F., Mochizuki, Aaron Y., Orpilla, Joey R., Hugo, Willy, Lee, Alexander H., Davidson, Tom B., Wang, Anthony C., Ellingson, Benjamin M., Rytlewski, Julie A., Sanders, Catherine M., Kawaguchi, Eric S., Du, Lin, Li, Gang, Yong, William H., Gaffey, Sarah C., Cohen, Adam L., Mellinghoff, Ingo K., Lee, Eudocia Q., Reardon, David A., O’Brien, Barbara J., Butowski, Nicholas A., Nghiemphu, Phioanh L., Clarke, Jennifer L., Arrillaga-Romany, Isabel C., Colman, Howard, Kaley, Thomas J., de Groot, John F., Liau, Linda M., Wen, Patrick Y., Prins, Robert M.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

CTNI-12. PRELIMINARY RESULTS OF THE ABEMACICLIB ARM IN THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGHT): A PHASE II PLATFORM TRIAL USING BAYESIAN ADA... gan Wen, Patrick, Trippa, Lorenzo, Lee, Eudocia, Fell, Geoffrey, Rahman, Rifaquat, Arrillaga-Romany, Isabel, Touat, Mehdi, McCluskey, Christine, Brunno, Jennifer, Gaffey, Sarah, Drappatz, Jan, Lassman, Andrew, Galanis, Evanthia, Ahluwalia, Manmeet, Colman, Howard, Nabors, Louis, Hepel, Jaroslaw, Elinzano, Heinrich, Schiff, David, Chukwueke, Ugonma, Beroukhim, Rameen, Nayak, Lakshmi, Mcfaline-Figueroa, Jose, Batchelor, Tracy, Rinne, Mikael, Kaley, Thomas, Lu-Emerson, Christine, Bi, Wenya Linda, Arnaout, Omar, Peruzzi, Pier-Paolo, Doherty, Lisa, Haas-Kogan, Daphne, Tanguturi, Shyam, Cagney, Daniel, Aizer, Ayal A, Welch, Mary, Lavallee, Maria, Fisher-Longden, Brittany, Dowling, Shanna, Geduldig, Jack, Santagata, Sandro, Meredith, David, Chiocca, E Antonio, Reardon, David, Ligon, Keith, Alexander, Brian

Cael y testun llawn Cael y testun llawn

CTNI-11. CC-115 IN NEWLY DIAGNOSED MGMT UNMETHYLATED GLIOBLASTOMA IN THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGHT): A PHASE II RANDOMIZED BAYESIAN... gan Rahman, Rifaquat, Trippa, Lorenzo, Fell, Geoffrey, Lee, Eudocia, Arrillaga-Romany, Isabel, Touat, Mehdi, McCluskey, Christine, Brunno, Jennifer, Gaffey, Sarah, Drappatz, Jan, Lassman, Andrew, Galanis, Evanthia, Ahluwalia, Manmeet, Colman, Howard, Nabors, Louis, Hepel, Jaroslaw, Elinzano, Heinrich, Schiff, David, Chukwueke, Ugonma, Beroukhim, Rameen, Nayak, Lakshmi, Mcfaline-Figueroa, Jose, Batchelor, Tracy, Rinne, Mikael, Kaley, Thomas, Lu-Emerson, Christine, Bi, Wenya Linda, Arnaout, Omar, Haas-Kogan, Daphne, Tanguturi, Shyam, Cagney, Daniel, Aizer, Ayal A, Welch, Mary, Doherty, Lisa, Lavallee, Maria, Fisher-Longden, Brittany, Dowling, Shanna, Geduldig, Jack, Watkinson, Fiona, Santagata, Sandro, Meredith, David, Chiocca, E Antonio, Reardon, David, Ligon, Keith, Alexander, Brian, Wen, Patrick

Cael y testun llawn Cael y testun llawn